Evidence map›Paper›PMID 20569817›Full record

ReviewClinics in perinatology2010

Pathophysiology and treatment of septic shock in neonates.

James L Wynn, Hector R Wong

2 registry-linked trialsAbstract readReview
In one paragraph

Review in Clinics in perinatology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 113 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
113citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03004482 suspendednot on this mapstarted 2015, after this paper: background citation

Noninvasive Monitoring and Diagnosis of Physiologic Disturbances in Term and Preterm Newborns Using Video Analysis Techniques

TypeobservationalSponsorAmerican University of Beirut Medical CenterRan2015 to 2023Enrolled80ConditionsNeonatal Intensive Care Unit
NCT03291496 active not recruitingnot on this mapstarted 2017, after this paper: background citation

Microfluidic Assessment of Clinical Outcomes in Preterm Newborns

TypeobservationalSponsorUniversity of FloridaRan2017 to 2026Enrolled293ConditionsNeonatal SEPSISArmsBlood Collection Preterm, Blood Collection Term, Adult Blood collection
3 · Its place in the literature

Who cites it

113 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Efficacy and Safety of Vasopressin and Terlipressin in Preterm Neonates: A Systematic Review.International journal of environmental research and public health · 2022
    Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Plasma transfusion in neonatal sepsis.World journal of pediatrics : WJP · 2026
    Article
  12. Review
  13. Timely administration of antibiotics for neonatal sepsis in the neonatal intensive care unit: A quality improvement initiative.Journal of perinatology : official journal of the California Perinatal Association · 2026
    Article
  14. Journal of clinical medicine · 2026
    Article
  15. Article
  16. Duration of Antibiotic Therapy forThe journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2026
    Article
  17. Article
  18. Review
  19. Article
  20. Review

53 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

James L WynnDivision of Neonatal-Perinatal Medicine, Department of Pediatrics, Duke University, 2424 Hock Plaza, Suite 504, DUMC Box 2739, Durham, NC 27710, USA. james.wynn@duke.edu <james.wynn@duke.edu>
Hector R Wong

Funding

Genomic analysis of pediatric SIRS and septic shockR01GM064619 · NIGMS · CINCINNATI CHILDRENS HOSP MED CTR · PI WONG, HECTOR R. · 2003 to 2009
$3.0M
THE PEDIATRIC SEPSIS BIOMARKER RISK MODELRC1HL100474 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI WONG, HECTOR R. · 2009 to 2010
$1000k
NHLBI NIH HHS RC1 HL100474NIGMS NIH HHS R01 GM064619
6 · The paper itself

Abstract

Neonatal septic shock is a devastating condition associated with high morbidity and mortality. Definitions for the sepsis continuum and treatment algorithms specific for premature neonates are needed to improve studies of septic shock and assess benefit from clinical interventions. Unique features of the immature immune system and pathophysiologic responses to sepsis, particularly those of extremely preterm infants, necessitate that clinical trials consider them as a separate group. Keen clinical suspicion and knowledge of risk factors will help to identify those neonates at greatest risk for development of septic shock. Genomic and proteomic approaches, particularly those that use very small sample volumes, will increase our understanding of the pathophysiology and direct the development of novel agents for prevention and treatment of severe sepsis and shock in the neonate. Although at present antimicrobial therapy and supportive care remain the foundation of treatment, in the future immunomodulatory agents are likely to improve outcomes for this vulnerable population.

Indexed as

Acute-Phase ProteinsAnti-Infective AgentsBlood Coagulation DisordersComplement System ProteinsEndothelium, VascularGenomicsHumansHydrocortisoneImmunity, InnateImmunity, Maternally-AcquiredInfant, NewbornIntercellular Signaling Peptides and ProteinsMultiple Organ FailureNeutrophilsOpsonin ProteinsProteomicsAcute-Phase ProteinsAnti-Infective AgentsComplement System ProteinsHydrocortisoneIntercellular Signaling Peptides and ProteinsOpsonin Proteins

Identifiers

PMID20569817
PMCPMC2891980

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.